In a patient sample-based study, the positive expression correlation was observed between CSNK2β and XIAP in cholangiocarcinoma patients and CSNK2β was significantly associated with TNM stage (P= 0.036) (Zhou et al., 2014[58]). The gene discussed is CSNK2B; the disease is cholangiocarcinoma.